Adam Litwin has wanted to be a doctor since he was a child—so much so that in 2000, he went to jail for impersonating one. Now, almost 20 years later, he's graduated from medical school, but he still has to overcome his checkered past, Soumya Karlamangla writes for the Los Angeles Times.
As enrollment in Medicare Advantage (MA) plans continues to grow, data suggest more health insurance companies are expected to expand their MA business segments—at rates faster than their traditional Medicare business lines, according to a recent HealthEdge report.
Scores of medical devices that are currently in use have never been assessed by security researchers, so to build an understanding of security flaws, organizers of the BioHacking village at DefCon built a mock hospital equipped with "both new and older devices for hackers to tear apart," Lily Newman writes for WIRED.
The number of U.S. pharmacies dispensing prescriptions for the opioid overdose reversal drug naloxone doubled from 2017 to 2018, but there's still only one naloxone prescription dispensed for every 69 high-dose opioid prescriptions, according to a CDC report released Tuesday.
FDA on Tuesday said some data submitted to the agency during its approval process for Zolgensma, a gene therapy drug priced at $2.1 million, were manipulated, but the agency stressed the remaining data show the product should remain on the market.